Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ryanodine receptor gene expression thymomas

L L Kusner1, A Mygland, H J Kaminski

  • 1Department of Neurology, Case Western Reserve University School of Medicine, Department of Veterans Affairs Medical Center, University Hospitals of Cleveland, Ohio 44106, USA.

Muscle & Nerve
|September 15, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis.

European journal of neurology·2017
Same author

CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.

Journal of neurology·2016
Same author

GR gene polymorphism is associated with inter-subject variability in response to glucocorticoids in patients with myasthenia gravis.

European journal of neurology·2016
Same author

Functioning of long-term survivors of first-ever intracerebral hemorrhage.

Acta neurologica Scandinavica·2014
Same author

Organizational changes aiming to reduce iv tPA door-to-needle time.

Acta neurologica Scandinavica·2013
Same author

Response to letter to the editor; ANE-O-03-12-096.

Acta neurologica Scandinavica·2013

Skeletal muscle Ryanodine receptor (RyR) is found in thymus tissues, but not in thymomas. This suggests RyR in thymoma is not the cause of immune sensitization in myasthenia gravis patients.

Area of Science:

  • Immunology
  • Neurology
  • Molecular Biology

Background:

  • Ryanodine receptor (RyR) antibodies are detected in myasthenia gravis patients with thymoma.
  • Antibody titers correlate with disease severity and mortality.

Purpose of the Study:

  • To determine if skeletal muscle RyR expression in thymic tissues triggers immune responses in thymoma-associated myasthenia gravis.
  • Investigate the source of immune sensitization to RyR.

Main Methods:

  • Reverse transcription and semiquantitative polymerase chain reaction were used to analyze RyR gene expression.
  • RyR gene expression was quantified in hyperplastic, normal, and thymoma thymus tissues.

Main Results:

  • Significant RyR gene expression was observed in hyperplastic and normal thymus tissues.

Related Experiment Videos

  • RyR gene transcripts were statistically less prevalent in thymomas compared to hyperplastic and normal thymus (P < 0.05).
  • RyR transcript presence in thymomas did not correlate with myasthenic symptoms, thymic pathology, or serum RyR antibody levels.

    • Conclusions:

    • Skeletal muscle RyR within thymoma is unlikely to be the primary antigen responsible for immune sensitization in thymoma-associated myasthenia gravis.
    • The study does not support thymic RyR as the source of immune response in this condition.